OP2Lysis Development SA
Ouverture de faillite 1.0 FTEThe score of OP2Lysis Development shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2022 → 2024: Equity +27 % Total assets +4 % Headcount (avg FTE) -41 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
OP2Lysis Development's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 18 Jun 2025
- Year ended 31 Dec 2023filed on 13 Jun 2024
- Year ended 31 Dec 2022filed on 28 Jul 2023
OP2Lysis Development's financial analysis
- Solvency60.1%sector median: 57.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of OP2Lysis Development
OP2Lysis Development's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0769.816.843
- VAT number
- BE0769816843
- Peppol
- Not found on Peppol as of 07 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 17 Jun 2021
- Registered office
- 4000 Liège
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2024 · filed on 18 Jun 2025
- Activity
- Research and experimental development on biotechnology (NACE 72101)
OP2Lysis Development (SA) has been based in Liège since 2021, active in: research and experimental development on biotechnology. For 2024, it reports a net loss of 116,187 € and equity of €1.82m; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 60.1%, above the median of its sector (57.9%).
Companies similar to OP2Lysis Development
Companies in the same business, of comparable size and area, outside its group.
- Wishbone Research and experimental development on natural sciences and engineering Flémalle · balance sheet €3.39m
- XomeXBio Research and experimental development on natural sciences and engineering Charleroi · balance sheet €3.50m
- Ipratech Research and experimental development on natural sciences and engineering Charleroi · balance sheet €4.29m
- Genflow Biosciences Research and experimental development on natural sciences and engineering Charleroi · balance sheet €3.74m
- ExeVir Bio Research and experimental development on natural sciences and engineering Ghent · balance sheet €3.76m
- Tanai Therapeutics Research and experimental development on natural sciences and engineering Ghent · balance sheet €3.87m
- Olfadog Biotech Research and experimental development on natural sciences and engineering Waterloo · balance sheet €1.80m
- Depot Solar 21 Research and experimental development on natural sciences and engineering Herentals · balance sheet €1.62m
Frequently asked questions about OP2Lysis Development
What is the revenue of OP2Lysis Development?
OP2Lysis Development files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of OP2Lysis Development?
In Belgium, the VAT number is the company number prefixed with BE: BE0769816843 for OP2Lysis Development, if the company is VAT-registered. Its company number (CBE) is 0769.816.843.
Where is the registered office of OP2Lysis Development?
According to the CBE register, the registered office of OP2Lysis Development is in 4000 Liège.
What is the equity of OP2Lysis Development?
At the close of the 2024 financial year, the equity of OP2Lysis Development amounts to 1,822,074 €, a solvency of 60.1% of total assets.
How many people work at OP2Lysis Development?
1.0 full-time equivalents on average according to the 2024 social balance sheet.
Who manages OP2Lysis Development?
The register lists 4 active mandates at OP2Lysis Development. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of OP2Lysis Development
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →